Mainolfi Nello (CIK 1821189) reported 29 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-07). Recent activity: Buy KYMR (50,000 shares), Sell KYMR (50,000 shares), Buy KYMR (80,000 shares), Sell KYMR (1,883 shares), Sell KYMR (6,626 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 50,000 | $104,000 |
| 2026-07-07 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 50,000 | $6.0M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 80,000 | $166,400 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 1,883 | $212,411 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 6,626 | $755,204 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 24,105 | $2.8M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 44,050 | $5.1M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 3,336 | $388,841 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 1,501 | $139,308 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 19,764 | $1.8M |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 5,434 | $491,179 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 3,293 | $302,166 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 30,000 | $62,400 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 8 | $748 |
| 2026-01-06 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 3,118 | $99,994 |
| 2025-12-31 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 30,000 | $62,400 |
| 2025-12-31 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 23,986 | $1.9M |
| 2025-12-31 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 6,014 | $472,219 |
| 2025-12-17 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 2,595 | $99,985 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 100,000 | $208,000 |
| 2025-12-08 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 100,000 | $8.9M |
| 2025-10-29 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 30,000 | $62,400 |
| 2025-10-29 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 1,862 | $111,199 |
| 2025-10-29 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 24,511 | $1.5M |
| 2025-10-29 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 3,627 | $222,915 |
Source: SEC Form 4 filings · as of 2026-07-07